Compartment-specific PPARδ activity controls the outcome of cancer–immune cell competition and immunotherapy efficacy

T cells sensitize immunotherapy-resistant microsatellite stable metastatic colorectal cancer to checkpoint blockade in mice, and pharmacological or genetic PPARδ activation enhances human chimeric antigen receptor T cell function. These findings identify compartment-specific PPARδ activity as a targetable driver of immune cell fitness that can be harnessed to improve outcomes in immunotherapy-resistant tumors.

Authors

Institutions

Publication Details

Journal
Nature Immunology
Published
2026-10-14
DOI
https://doi.org/10.1038/s41590-026-02685-2
Primary Topic
Peroxisome Proliferator-Activated Receptors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Compartment-specific PPARδ activity controls the outcome of cancer–immune cell competition and immunotherapy efficacy

Jill Habel, Peter M.K. Westcott, Semir Beyaz, Laura Herrero et al.
Nature Immunology
Peroxisome Proliferator-Activated Receptors
article

Compartment-specific PPARδ activity controls the outcome of cancer–immune cell competition and immunotherapy efficacy

Jill Habel, Peter M.K. Westcott, Semir Beyaz, Laura Herrero, John Erby Wilkinson, David E. Rivadeneira, Saar I. Gill, Nils Wellhausen, Nathalie Y.R. Agar, Charlie Chung, Vinay Mandati, Philip Moresco, Ilgin Ergin, Vyom Shah, Samuel Edward Weinberg, Paul Bunk, Julia Rose Bonney, Sarah Shao, Lokesh B. S. S. Kumar, Rachel Rubino, Timothy Maher
article en

Abstract

T cells sensitize immunotherapy-resistant microsatellite stable metastatic colorectal cancer to checkpoint blockade in mice, and pharmacological or genetic PPARδ activation enhances human chimeric antigen receptor T cell function. These findings identify compartment-specific PPARδ activity as a targetable driver of immune cell fitness that can be harnessed to improve outcomes in immunotherapy-resistant tumors.

Nature Immunology
Northwestern University (US), Brigham and Women's Hospital (US), Harvard University (US), Cold Spring Harbor Laboratory (US), University of Michigan (US), Instituto de Salud Carlos III (ES), Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (ES), Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US), Parker Institute for Cancer Immunotherapy (US), Dana-Farber Cancer Institute (US), Huntington Hospital (US), Institut de Biomedicina de la Universitat de Barcelona, Rutgers New Jersey Medical School (US), Stony Brook University (US), Universitat de Barcelona (ES), University of Pennsylvania (US)
Good health and well-being
Openalex Percentile: Top 24%
Peroxisome Proliferator-Activated Receptors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.